PropertyValue
?:abstract
  • We argue that the evidence remains insufficient for use of intraoperative radiotherapy (IORT) in women with early stage breast cancer outside of a clinical trial, as the recently reported TARGIT-A trial does not provide sufficient evidence to conclude that IORT is superior to no radiotherapy.
is ?:annotates of
?:creator
?:doi
  • 10.1038/s41571-020-00444-2
?:doi
?:journal
  • Nat_Rev_Clin_Oncol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/0c58d3c00e4836b9f40ff59c14cb281ae261557f.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7576112.xml.json
?:pmcid
?:pmid
?:pmid
  • 33087894.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Intraoperative radiotherapy for early breast cancer — insufficient evidence to change practice
?:type
?:year
  • 2020-10-21

Metadata

Anon_0  
expand all